Literature DB >> 3034072

Altered hepatic vasopressin and alpha 1-adrenergic receptors after chronic endotoxin infusion.

B L Roth, J A Spitzer.   

Abstract

Sepsis and septic shock are complicated by a number of hemodynamic and metabolic aberrations. These include catecholamine refractoriness and altered glucose metabolism. Recently, a nonshock rat model of continuous endotoxin infusion via an implanted osmotic pump was developed that reproduces some of the metabolic and cardiovascular findings of human sepsis. By using this model, we have found a decreased number of hepatic plasma membrane alpha 1-adrenergic and [Arg8]vasopressin receptors in rats continuously infused with endotoxin. There was a significant decrease in [3H]prazosin (35 +/- 7%) and [3H] [Arg8]vasopressin (43 +/- 8%) receptors after 30 h of continuous endotoxin infusion with no change in affinity. The ability of norepinephrine to form the high-affinity complex with alpha 1-adrenergic receptors was not altered after chronic endotoxin infusion. The results are consistent with the concept that alterations in receptor number might underlie certain of the metabolic consequences of chronic sepsis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034072     DOI: 10.1152/ajpendo.1987.252.5.E699

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Synthesis and evaluation of C-11, F-18 and I-125 small molecule radioligands for detecting oxytocin receptors.

Authors:  Aaron L Smith; Sara M Freeman; Jeffery S Stehouwer; Kiyoshi Inoue; Ronald J Voll; Larry J Young; Mark M Goodman
Journal:  Bioorg Med Chem       Date:  2012-02-25       Impact factor: 3.641

2.  Hemodynamic management of septic shock.

Authors:  Daniel De Backer
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

3.  Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells.

Authors:  M Burnier; G Centeno; G Waeber; C Centeno; E Bürki
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

Review 4.  Management of vasodilatory shock: defining the role of arginine vasopressin.

Authors:  Martin W Dunser; Volker Wenzel; Andreas J Mayr; Walter R Hasibeder
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

6.  Kinetics of diacylglycerol accumulation in response to vasopressin stimulation in hepatocytes of continuously endotoxaemic rats.

Authors:  E B Rodriguez de Turco; J A Spitzer
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

7.  LPS differentially affects vasoconstrictor responses: a potential role for RGS16?

Authors:  M C Hendriks-Balk; M Tjon-Atsoi; N Hajji; A E Alewijnse; S L M Peters
Journal:  J Physiol Biochem       Date:  2009-03       Impact factor: 4.158

8.  Which variables are associated with blood glucose levels outside the target range in surgical critically ill patients? A retrospective observational study.

Authors:  Manfred Weiss; Martina Kron; Birgit Hay; Michael Taenzer; Peter Radermacher; Michael Georgieff
Journal:  Patient Saf Surg       Date:  2011-04-06

Review 9.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

10.  Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome.

Authors:  Günter Luckner; Martin W Dünser; Karl-Heinz Stadlbauer; Viktoria D Mayr; Stefan Jochberger; Volker Wenzel; Hanno Ulmer; Werner Pajk; Walter R Hasibeder; Barbara Friesenecker; Hans Knotzer
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.